Nowadays, especially through the advent of systems biology, and the ability to generate predictive models, it is even more important to transform biology from a qualitative to a quantitative science. Interactions between proteins not only need to be identified, but their equilibrium rate constants need to be determined as well. Here we describe a very elegant and simple system to obtain quantitative data for protein-protein interactions using cell-free protein biosynthesis in combination with Microscale Thermophoresis. We have been able to characterize the interaction of Calmodulin with Ca2+ as well as its ligand M13 straight in the in vitro synthesis reaction. Furthermore, we are demonstrating the generic applicability of this approach with another set of proteins, an Antibody fragment and Cyclophilin A. All this work has been done without tedious expression and prior purification of the interacting proteins.
Have a question about Monolith?
Contact SpecialistSee more related content
NanoTemper Technologies introduced Monolith X, adding breakthrough Spectral Shift technology to their top-selling Monolith product line.
2:20Introducing Monolith X - the only way to get binding affinities in solution using very minimal sample
NanoTemper’s Monolith wins top global design award: Red Dot Award
NanoTemper’s newest Monolith instrument has been awarded the Red Dot Award, an internationally recognized seal of excellence in design. Both bold aesthetics and user-friendly design have always...
10 terms to help you more easily understand targeted protein degradation
Targeted Protein Degradation (TPD), a relatively new therapeutic approach, is making waves by targeting otherwise ‘undruggable’ proteins. PROTACs are the best-understood protein degraders, with...
14:01The desire to use technology that allows you to study membrane proteins in close-to-native conditions is specifically important when it comes to interaction measurements. It’s always a question how mu
35:47Targeted protein degradation using molecular glues or proteolysis-targeting chimeras (PROTACs) is an increasingly important therapeutic modality, especially for undruggable targets. Even with candidat
Why so many companies are betting on PROTACs as a superior therapeutic modality
With PROTACs currently in the clinical and preclinical stages, they are making exciting progress towards successfully treating patients who have been waiting for effective therapies for certain...
35:24Effect of different SARS-CoV-2 variants on COVID 19 assays and vaccines
SARS-CoV-2, the causative agent of COVID-19, has an ssRNA genome of almost 30kb that encodes for a total of 26 proteins. Among the four structural viral protein, in particular the S protein stands out
MST and TRIC technology to reliably study PROTAC binary and ternary binding in drug development
27:20Explore the complexities and drivers of molecular interactions with Dr. Tom Laue from the University of New Hampshire. He presented as a keynote speaker in the Protein Stability & Function: Can't have
33:11Dr. Leah Pandiscia and Dr. Daniel Turman review how to integrate the Prometheus Panta and Monolith instruments in a characterization workflow demonstration, showing how to maximize stability and funct
NanoTemper’s Monolith wins top global design award: iF DESIGN AWARD 2021
NanoTemper’s newest Monolith instrument has been awarded the globally renowned iF DESIGN AWARD 2021. User-friendly design has always been a core focus in NanoTemper’s product development....
25:40Are you struggling to tame your mischievous membrane proteins? Find out how NanoTemper can help you to characterize even the most challenging membrane protein samples. You will learn how Prometheus ca
Targeted protein degradation promises to lead the way to effective drugs for challenging targets